FDA — authorised 30 December 1992
- Marketing authorisation holder: KING PHARMS
- Status: approved
FDA authorised Alocril on 30 December 1992
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 30 December 1992; FDA authorised it on 8 December 1999.
KING PHARMS holds the US marketing authorisation.